EP3154566

ACTRII ANTAGONIST FOR THE TREATMENT OR PREVENTION OF A CUTANEOUS ULCER IN A SUBJECT THAT HAS ANEMIA

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    12.6.2015
  • EP published:
    3.8.2022
  • EP application number:
    15806256.2
  • Max expiry date:
    11.6.2035
  • Title in English:
    ACTRII ANTAGONIST FOR THE TREATMENT OR PREVENTION OF A CUTANEOUS ULCER IN A SUBJECT THAT HAS ANEMIA
  • Language of the patent:
    English

Timeline

Today
12.6.2015EP application
3.8.2022EP Publication

Owner

  • Name:
    Acceleron Pharma Inc.
  • Address:
    128 Sidney Street, Cambridge, MA 02139, US

Inventor

  • Name:
    ATTIE, Kenneth, M.
  • Address:
    Boston, MA 02116, US

Priority

  • Number:
    201462012109 P
  • Date:
    13.6.2014
  • Country:
    US
  • Number:
    201462045808 P
  • Date:
    4.9.2014
  • Country:
    US

Classification

  • Categories:
    A61K 38/18, A61K 39/395, A61P 17/02, C07K 19/00

Upload documents